Free market activists slam Trump's international drug pricing index

Washington Times

21 May 2019 - Rep. Andy Biggs: 'Seems to me like we're importing drug controls'.

Free market activists on Tuesday slammed an administration plan that would align the price of certain Medicare drugs with those in other countries, saying it would “import price controls” and undercut President Trump’s message on Democrats’ embrace of socialism.

FreedomWorks, a conservative pressure group, will join 75 activists in lobbying against the plan on Capitol Hill on Wednesday.

They’ve got an ally in Rep. Andy Biggs, Arizona Republican and a strenuously objector to the administration’s push for an International Pricing Index. As crafted, the index would allow the U.S. to set prices for doctor-administered drugs under Medicare Part B that are only slightly higher than what purchasers in Japan, Canada and major European nations pay.

Read Washington Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing